Intellia Therapeutics, Inc. - NTLA
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 27, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | THE GOLDMAN SACHS GROUP, INC. | 2.7% | 3,157,178 | View |
| Feb 12, 2026 | SCHEDULE 13G/A | GOLDMAN SACHS & CO. LLC | 2.7% | 3,157,178 | View |
| Feb 11, 2026 | SCHEDULE 13G/A | Contrarius Investment Management Ltd | 0.6% | 714,480 | View |
| Feb 11, 2026 | SCHEDULE 13G/A | Contrarius Investment Management (Bermuda) Ltd | 0.6% | 714,480 | View |
| Feb 03, 2026 | SCHEDULE 13G/A | ARK Investment Management LLC | 12.27% | 14,207,324 | View |
| Feb 03, 2026 | SCHEDULE 13G/A | Catherine D. Wood | 12.27% | 14,207,324 | View |
| Jan 30, 2026 | SCHEDULE 13G/A | The Vanguard Group | 11.23% | 13,010,001 | View |
| Nov 12, 2025 | SCHEDULE 13G | THE GOLDMAN SACHS GROUP, INC. | 5.1% | 5,498,262 | View |
| Nov 12, 2025 | SCHEDULE 13G | GOLDMAN SACHS & CO. LLC | 5.1% | 5,498,262 | View |
| Nov 12, 2025 | SCHEDULE 13G | Contrarius Investment Management Ltd | 5.5% | 5,889,936 | View |
| Nov 12, 2025 | SCHEDULE 13G | Contrarius Investment Management (Bermuda) Ltd | 5.5% | 5,889,936 | View |
| Nov 04, 2025 | SCHEDULE 13G/A | ARK Investment Management LLC | 11.1% | 11,919,178 | View |
| Nov 04, 2025 | SCHEDULE 13G/A | Catherine D. Wood | 11.1% | 11,919,178 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.